Capital Fund Management (CFM)
PRCT icon

Capital Fund Management (CFM)’s Procept Biorobotics PRCT Stock Holding History

Capital Fund Management (CFM)’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$886K Buy
39,251
+21,593
+122% +$541K ﹤0.01% 1729
2026
Q1 		$442K Buy
+17,658
New +$498K ﹤0.01% 1901
2025
Q2 		– Sell
-27,371
Closed -$1.59M – 2485
2025
Q1 		$1.59M Buy
27,371
+14,023
+105% +$957K ﹤0.01% 1511
2024
Q4 		$1.07M Buy
+13,348
New +$1.14M ﹤0.01% 1733

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Fund Management (CFM)'s PRCT Position: Q2 2026 in Review

Capital Fund Management (CFM) increased its Procept Biorobotics (PRCT) stake by 122% in Q2 2026, buying an estimated $541K and bringing the position to 39,251 shares worth $886K. The position accounts for ﹤0.01% of the portfolio, ranked #1729.

Capital Fund Management (CFM) first reported a position in PRCT in Q4 2024 and has held it in 4 quarters since. The position peaked at $1.59M in Q1 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Capital Fund Management (CFM) held 39,251 shares of Procept Biorobotics worth $886K as of Q2 2026.
  • Capital Fund Management (CFM) bought 21,593 Procept Biorobotics shares in Q2 2026, an estimated $541K.
  • Procept Biorobotics made up ﹤0.01% of Capital Fund Management (CFM)'s portfolio in Q2 2026, its #1729 holding.
  • Capital Fund Management (CFM) first reported a position in Procept Biorobotics in Q4 2024 and has held it in 4 quarters since.
  • Capital Fund Management (CFM)'s Procept Biorobotics position peaked at $1.59M in Q1 2025.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.